Department of Microbiology; Tumor and Cell Biology; Karolinska Institutet; Stockholm, Sweden.
Oncoimmunology. 2013 Dec 1;2(12):e26744. doi: 10.4161/onci.26744. Epub 2013 Oct 22.
We observed a cell concentration-dependent differentiation switch among cultured dendritic cells (DCs) triggered by lactic acid, a product of glycolytic metabolism. In particular, while interleukin (IL)-12, IL-23, and tumor necrosis factor α (TNFα)-producing, migratory DCs developed in sparse cultures, IL-10-producing, non-migratory DCs differentiated in dense cultures. This points to a novel opportunity for tailoring DC-based anticancer therapies through metabolism modulation in developing DCs.
我们观察到,培养的树突状细胞 (DC) 在乳酸的作用下发生细胞浓度依赖性分化转换,乳酸是糖酵解代谢的产物。具体而言,稀疏培养时会产生产生白细胞介素 (IL)-12、IL-23 和肿瘤坏死因子 α (TNFα) 的迁移型 DC,而在密集培养时则分化为产生 IL-10 的非迁移型 DC。这为通过调节正在发育的 DC 中的代谢来定制基于 DC 的抗癌疗法提供了新的机会。